By Sheri Kasprzak
Atlanta, March 4 - Oxigene Inc. said it raised $15,012,527 in a direct placement of stock.
The company sold 3,336,117 shares at $4.50 each to institutional investors.
The shares were sold under Oxigene's shelf registration.
Legg Mason Wood Walker, Inc. and Lazard Freres & Co. LLC were the placement agents.
Based in Waltham, Mass., Oxigene is a pharmaceutical company focused on small-molecule therapeutics used to treat cancer and eye diseases. The proceeds from the offering will be used to accelerate the development of product candidates in oncology and ophthalmology.
| Issuer: | Oxigene Inc.
|
| Issue: | Stock
|
| Amount: | $15,012,527
|
| Shares: | 3,336,117
|
| Price: | $4.50
|
| Warrants: | No
|
| Placement agent: | Legg Mason Wood Walker Inc. and Lazard Freres & Co. LLC
|
| Settlement date: | March 4
|
| Stock price: | $5.33 at close March 3
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
